↓ Skip to main content

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease

Overview of attention for article published in Drug Safety, November 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

policy
1 policy source

Readers on

mendeley
50 Mendeley
Title
Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease
Published in
Drug Safety, November 2012
DOI 10.2165/00002018-200326060-00002
Pubmed ID
Authors

Edwin J. Wagen, Maurice P.A. Zeegers, Constant P. van Schayck, Emiel F.M. Wouters

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 2%
Germany 1 2%
Unknown 48 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 18%
Student > Master 9 18%
Student > Ph. D. Student 5 10%
Other 5 10%
Student > Bachelor 3 6%
Other 9 18%
Unknown 10 20%
Readers by discipline Count As %
Medicine and Dentistry 11 22%
Psychology 8 16%
Nursing and Health Professions 5 10%
Agricultural and Biological Sciences 4 8%
Neuroscience 2 4%
Other 5 10%
Unknown 15 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2013.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from Drug Safety
#916
of 1,852 outputs
Outputs of similar age
#86,085
of 285,244 outputs
Outputs of similar age from Drug Safety
#379
of 812 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,244 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.